CME GROUP INC（CME）の決算・業績分析
CME GROUP INCの2025年有価証券報告書をAI分析。売上高$6.5B(+6.4%)。営業利益$4.2B。Financials。
目次
CME GROUP INCの2025年度 業績サマリー
CME GROUP INC（証券コード: CME）の2025年度決算・業績分析。売上高は$6.5B（前年比+6.4%）。営業利益は$4.2B（前年比+7.6%）。純利益は$4.1B（前年比+15.5%）。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。
CME GROUP INCの2024年度 注目ポイント
※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。
- CME Group achieved 7.0% YoY revenue growth to $5.0B (XBRL), with operating income rising 14.0% to $3.0B (XBRL) and net income surging 22.4% to $3.2B (XBRL).
- Net margin reached 64.3% (XBRL), the highest among all metrics, reflecting strong profitability despite a high debt-to-equity ratio of 3.85x (XBRL).
- Shareholder returns totaled $2.6B (XBRL) through dividends, with a payout ratio of 81.6% (XBRL), indicating a heavy focus on returning capital to investors.
CME GROUP INCの売上高変化の要因
- •Total revenue grew 7.0% YoY to $5.0B (XBRL), driven by high-quality products and clearing services (10-K). Historical data shows revenue increased from $4.7B in FY2023 to $5.0B in FY2024 (XBRL). Segment-specific revenue figures are not disclosed in the XBRL data or 10-K text (N/A).
CME GROUP INCの営業利益変化の要因
- •Operating income rose 14.0% YoY to $3.0B (XBRL), with operating margin at 60.1% (XBRL). Net income surged 22.4% YoY to $3.2B (XBRL), achieving a net margin of 64.3% (XBRL). EBITDA reached $3.2B (62.8% margin) (XBRL). Gross profit data is not available (N/A).
CME GROUP INCの事業リスクと対応
Global market, economic, and political conditions impact trading volumes and revenue (10-K).
Heavy regulation imposes compliance costs and risks to regulated status (10-K).
Legislative/regulatory changes could increase costs or alter business practices (10-K).
Potential transaction taxes or tax changes may reduce trading activity (10-K).
Consolidation/expansion in customer base may affect trading volumes and liquidity (10-K).
CME GROUP INCの今後の見通し・業績予想
CME GROUP INCの事業内容
CME Group Inc. operates as a global derivatives exchange, generating revenue through trading fees, clearing services, and market data provision (10-K). Its core business includes futures and options trading, cash/OTC trading via BrokerTec and EBS, and central counterparty clearing services (10-K). The company's competitive advantages include product diversity, liquidity, and advanced platforms like CME Globex (10-K). Key customers are institutional investors, traders, and corporations, with no significant customer concentration (10-K).
CME GROUP INCのAI業績分析レポート（2024年度）
CME Group Inc. FY2024 Annual Report Analysis
Highlights
Business Overview
CME Group operates as a derivatives exchange, offering trading, clearing, and market data services (10-K). Key segments include futures/OTC trading and central counterparty clearing (10-K). Competitive advantages include product diversity and platforms like CME Globex (10-K). No significant customer concentration exists (10-K).
Revenue Analysis
Total revenue increased to $5.0B (XBRL), up 7.0% YoY. Historical data shows a 5.3% CAGR in revenue over five years (XBRL). Segment-specific revenue figures are not disclosed (N/A).
Profitability Analysis
Operating income rose 14.0% YoY to $3.0B (XBRL), with operating margin at 60.1% (XBRL). Net income surged 22.4% YoY to $3.2B (XBRL), achieving a net margin of 64.3% (XBRL). EBITDA reached $3.2B (62.8% margin) (XBRL). Gross profit data is not available (N/A).
Balance Sheet Analysis
Total assets declined from $174.2B in FY2023 to $129.7B in FY2024 (XBRL). Total equity fell to $26.7B (XBRL). Cash reserves stood at $2.7B (XBRL), but the D/E ratio of 3.85x (XBRL) indicates high leverage. Current ratio is 1.02x (XBRL).
Cash Flow Analysis
Operating cash flow was $3.1B (XBRL), with FCF of $3.0B after $90M in CapEx (XBRL). Dividends paid totaled $2.6B (XBRL), reflecting a payout ratio of 81.6% (XBRL). Investing activities consumed $490M (XBRL), while financing activities showed a net outflow of $25.4B (XBRL).
Working Capital Analysis
Receivables days: 39 days (XBRL); Payables days: 7 days (XBRL). Asset turnover: 0.04x (XBRL). No inventory data provided (N/A).
Risks
Outlook
Management expects economic uncertainty, competitive pressures, and regulatory developments to influence future results (10-K). Product diversity and liquidity remain critical growth drivers (10-K).
Historical Time Series
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | 4.3B | 4.9B | 4.9B | 4.7B | 5.0B | 5.6B |
| Operating Income | 2.6B | 2.6B | 2.6B | 2.6B | 3.0B | 3.4B |
| Net Income | 2.0B | 2.1B | 2.1B | 2.6B | 3.2B | 2.1B |
| Total Assets | 75.2B | 124.7B | 196.8B | 174.2B | 129.7B | 137.4B |
| Total Equity | 26.1B | 26.3B | 27.4B | 26.9B | 26.7B | 26.5B |
| Operating Cash Flow | 2.4B | 2.7B | 2.7B | 2.4B | 3.1B | 3.5B |
Financialsの企業一覧
CME GROUP INCと同じ「Financials」セクターの企業